Infective dose of foodborne pathogens in volunteers: A review

Journal of Food Safety

Volumn 21, Issue 1, 2001, Pages 49-68

  Kothary, Mahendra H ^a   Babu, Uma S ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; FOOD CONTAMINATION; FOOD SAFETY; GENETIC STRAIN; INFECTIVITY; MICROBIAL CONTAMINATION; PATHOGENESIS; RISK ASSESSMENT;

CAMPYLOBACTER JEJUNI; CRYPTOSPORIDIUM PARVUM; ENTAMOEBA COLI; ESCHERICHIA COLI; LISTERIA MONOCYTOGENES; SALMONELLA; SHIGELLA; VIBRIO CHOLERAE;

EID: 0034965726     PISSN: 01496085     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-4565.2001.tb00307.x     Document Type: Article

References (71)

1. Feeding tests of "pathogenic halophilic bacteria"
2. Foodbome outbreak of diarrheal illness associated with Cryptosporidium parvum-Minnesota, 1995
3. Experimental Campylobaeter jejuni infection in humans
4. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine
5. Protective efficacy in humans of killed whole-Vibrio oral cholera vaccine with and without the B subunit of cholera toxin
6. A review of human salmonellosis: I. Infective dose
7. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum
8. Cryptosporidium parvum: Intensity of infection and oocyst excretion patterns in healthy volunteers
9. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin
10. Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139
11. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602
12. Infective dose of Salmonella typhimurium in cheddar cheese
13. Salmonella eastbourne outbreak associated with chocolate
14. Role of the eaeA gene in experimental enteropathogenic Escheriehia coli infection
15. Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge
16. The infectivity of Cryptosporidium parvum in healthy volunteers
17. Pathogenesis of Echerichia coli diarrhea
18. The response of man to virulent Shigella flexneri 2a
19. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection
20. Inoculum size in shigellosis and implications for expected mode of transmission
21. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: Stimulation of anti-CFA (CFA/I) and antienterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes
22. Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2
23. Administration of purified colonization factor antigen (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli
24. 4, a coliform organism associated with infant diarrhea
25. Epidemic salmonellosis from cheddar cheese: Surveillance and prevention
26. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli
27. Chocolate bars contaminated with Salmonella napoli: An infectivity study
28. Experiments in feeding adult volunteers with Escherichia coli 55, BS, a coliform organism associated with infant diarrhea
29. Studies on the pathogenicity of Vibrio parahaemolyticus
30. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1
31. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain Ecsf2a-2
32. A modified Shigella volunteer challenge model in which the inoculum is achninistered with bicarbonate buffer: Clinical experience and implications for Shigella infectivity
33. Escherichia coli strains that cause diarrhea but do not produce heat labile or heat-stable enterotoxins and are non-invasive
34. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli Type I somatic pili parenteral vaccine in man
35. Volunteers studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: A review
36. Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin
37. Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery
38. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques
39. The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor
40. Studies with a new generation of oral attenuated Shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri
41. An analysis of the quantitative relationship between oral temperature and severity of illness in experimental shigellosis
42. Pathogenicity of enteroadherent Escherichia coli in adult volunteers
43. Experimental Human Salmonellosis; II. Immunity studies following experimenatal illness with Salmonella meleagridis & Salmonella anatum
44. Experimental human salmonellosis: I. Pathogenicity of strains of Salmonella meleagridis & Salmonella anatum obtained from spray-dried whole egg
45. Experimental human salmonellosis: III. Pathogenicity of strains of Salmonella newport, Salmonella derby & Salmonella bareilly obtained from spray-dried whole egg
46. Experimental human salmonellosis: IV Pathogenicity of strains of Salmonella pullorum obtained from spray-dried whole egg
47. Assessment of the dose-response relationship of Campylobacter jejuni
48. An outbreak of Cryptosporidiosis from fresh pressed apple cider
49. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers
50. Experimental Non-O Group 1 Vibrio cholerae gastroenteritis in humans
51. Characteristics of Shigella sonnei infection of volunteers: Signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances
52. Heterogeneity of enteroaggrgative Escherichia coli virulence demonstrated in volunteers
53. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults
54. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challneged with Cryptosporidium parvum
55. The experimental transmission of human intestinal protozoan parasites. I. Endamoeba coli cysts given in capsules
56. Infective dose of Campylobacter jejuni in milk
57. Validation of a volunteer model of cholera with frozen bacteria as the challenge
58. Studies on the enteropathogenic, facultatively halophilic bacteria, Vibrio parahaemolyticus. III. Enteropathogenicity
59. Human volunteer study on the pathogenicity of Vibrio parahaemolyticus
60. Which number of infecting bacteria is of clinical significance?
61. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge
62. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 E1 Tor Inaba three months after vaccination
63. Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111
64. Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal
65. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: Safety and efficacy against experimental challenge
66. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR
67. Challenge studies in volunteers using Escherichia coli strains with diffuse adherence to Hep-2 cells
68. Studies on pathogenic halophilic Vibrio bacteria
69. An outbreak of salmonellosis associated with a fatality in a healthy child: A large dose & severe illness
70. Development of a live, oral, attenuated vaccine against El Tor cholera
71. Clinical, bacteriological, and serological observations of two human volunteers following ingestion of Escherichia coli O127:B8